Imunon share price today

(IMNN)

Imunon share price is $0.79 & ₹67.55 as on 30 Dec 2024, 20.22 hrs IST

$0.79

Market is closed - opens 8 PM, 30 Dec 2024

View live Imunon share price in Dollar and Rupees. Guide to invest in Imunon from India. Also see the sentimental analysis on Indian investors investing in Imunon. Get details on the Indian mutual funds that are investing in Imunon. Get Analyst recommendations and forecasts along with all the Imunon's financials.

Imunon share price movements

Today's Low: $0.77
Today's High: $0.81
$0.79
2.38%
Downside
Day's Volatility :4.67%
Upside
2.35%
52 Weeks Low: $0.48
52 Weeks High: $3.65
$0.79
39.24%
Downside
52 Weeks Volatility :86.85%
Upside
78.36%

Imunon Returns

Period	Imunon Inc	Index (Russel 2000)
3 Months	-25.19%	0.0%
6 Months	-37.06%	0.0%
1 Year	16.6%	0.0%
3 Years	-56.67%	-21.3%

Imunon Key Statistics

in dollars & INR

Previous Close	$0.793
Open	$0.78
Today's High	$0.809
Today's Low	$0.7712
Market Capitalization	$11.5M
Today's Volume	$151.6K
52 Week High	$3.65
52 Week Low	$0.48
Revenue TTM	$125.0K
EBITDA	$-20.7M
Earnings Per Share (EPS)	$-1.91
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-148.12%

How to invest in Imunon from India?

It is very easy for Indian residents to invest directly in Imunon from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Imunon stock in both Indian Rupees (INR) and US Dollars (USD). Search for Imunon or IMNN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Imunon or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Imunon shares which would translate to 1.082 fractional shares of Imunon as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Imunon, in just a few clicks!

Returns in Imunon for Indian investors in Rupees

Investment Value

₹1,00,000

Imunon investment value today

Current value as on today

₹1,18,927

Returns

₹18,927

(+18.93%)

Returns from Imunon Stock

₹16,176 (+16.18%)

Dollar Returns

₹2,750 (+2.75%)

Indian investors sentiment towards Imunon

69%

Period: Sep 30, 2024 to Dec 29, 2025. Change in 30 Days versus previous period

Search volume for Imunon on INDmoney from India has grown in the last 30 days as on Dec 30, 2025. 69% more investors are searching Imunon in the last 30 days versus the previous period.

Global Institutional Holdings in Imunon

Geode Capital Management, LLC
0.87%
Renaissance Technologies Corp
0.44%
BlackRock Inc
0.40%
Vanguard Group Inc
0.34%
Citadel Advisors Llc
0.23%
State Street Corp
0.15%

Analyst Recommendation on Imunon

Buy

87%Buy

12%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Imunon(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Imunon

What analysts predicted

Upside of 1570.89%

Current:

$0.79

Target:

$13.20

Insights on Imunon

Price Movement
In the last 3 months, IMNN stock has moved down by -25.2%
Increasing Revenue
Revenue is up for the last 2 quarters, 125.0K → 7.05M (in $), with an average increase of 98.2% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -4.78M → -4.84B (in $), with an average decrease of 101100.0% per quarter
IMNN vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 24.3% return, outperforming this stock by 7.7%
Price to Sales
ForIMNN every $1 of sales, investors are willing to pay $56.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.4 for every $1 of sales.

Imunon Technicals Summary

Sell

Neutral

Buy

Imunon is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Imunon Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Imunon Inc	-8.37%	-37.06%	16.6%	-56.67%	-56.67%
Regeneron Pharmaceuticals, Inc.	-6.55%	-32.6%	-21.28%	12.81%	90.81%
Biontech Se	-2.77%	44.55%	1.43%	-55.8%	195.97%
Alnylam Pharmaceuticals, Inc.	-5.94%	-2.2%	22.08%	40.33%	105.82%
Vertex Pharmaceuticals Incorporated	-12.23%	-13.26%	-0.52%	86.14%	86.27%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Imunon Inc	NA	NA	NA	-1.68	-1.48	-0.67	NA	0.56
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.07	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Imunon Inc	Buy	$11.5M	-56.67%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	90.81%	17.67	33.61%
Biontech Se	Buy	$27.3B	195.97%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.3B	105.82%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.8B	86.27%	32.84	-4.51%

About Imunon

celsion is a biopharmaceutical company dedicated to the research and development of innovative, targeted therapies that address unmet medical needs in oncology. with the recent acquisition of egen, inc., celsion has become a fully integrated company with an extensive, complementary, multi-phase clinical pipeline; platform technologies for the discovery of novel, nucleic acid-based immunotherapies and other anti-cancer dna/rna therapies; and expertise from bench to bedside.

Organization	Imunon
Employees	33
CEO	Mr. Michael H. Tardugno
Industry	Miscellaneous

Management People of Imunon

Name	Title
Mr. Michael H. Tardugno	Executive Chairman
Dr. Stacy R. Lindborg Ph.D.	President, CEO & Director
Dr. Khursheed Anwer M.B.A., Ph.D.	Executive VP & Chief Scientific Officer
Mr. David G. Gaiero CPA	CFO & Corporate Secretary
Mr. Timothy J. Tumminello CPA	Chief Accounting Officer & Controller
Ms. Susan Mary Eylward	General Counsel & Corporate Secretary
Ms. Kristin Longobardi M.B.A.	Senior Vice President of Strategic Operations

Important FAQs about investing in Imunon from India :

What is Imunon share price today?

Imunon share price today stands at $0.79, Open: $0.78 ; Previous Close: $0.79 ; High: $0.81 ; Low: $0.77 ; 52 Week High: $3.65 ; 52 Week Low: $0.48. The stock opens at $0.78, after a previous close of $0.79. The stock reached a daily high of $0.81 and a low of $0.77, with a 52-week high of $3.65 and a 52-week low of $0.48.

Can Indians buy Imunon shares?

Yes, Indians can invest in the Imunon (IMNN) from India.

With INDmoney, you can buy Imunon at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Imunon at zero transaction cost.

How can I buy Imunon shares from India?

It is very easy to buy Imunon from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Imunon be purchased?

Yes, you can buy fractional shares of Imunon with INDmoney app.

What are the documents required to start investing in Imunon stocks?

To start investing in Imunon, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.